New Ray of Light for Epilepsy Research

Professor Richard Baines and Dr Carlo Giachello used a genetically-altered fruit fly to show that when nervous system activity is suppressed by shining yellow light through its embryo, it will not go on to develop symptoms of the disease when it gets older.

Though the procedure has only been used on flies, the team believe the Medical Research Council funded research for the first time proves that the development of epilepsy can be stopped in its tracks if treated early enough.

However, the technique developed and tested over three-years and published in Current Biology, will not benefit individuals who already have epilepsy.

Professor Baines said: “We’re excited by this discovery which we believe is proof of principle and a milestone in the way we understand epilepsy – though clearly more research is needed in mammals.

“But if these findings are taken to their logical conclusion, then we might envisage the possibility of being able to treat individuals at an early enough stage so they do not go on to develop the symptoms of epilepsy.

“After all, amazing though it might seem, the underlying biology of the central nervous system is the same in humans as it is in flies.”

People who suffer from epilepsy, due to the presence of a gene mutation, experience a period in the disease’s development called the epileptogenic process, a process by which a normal brain develops epilepsy.

Scientists have already discovered that starting treatment with antiepileptic drugs during the epileptogenic process will delay the inevitable onset of seizures.

However, this new procedure, which starts treatment during embryonic development and uses light to manipulate nervous system activity rather than drugs, seems to permanently prevent seizures.

Flies do not have spontaneous seizures like humans – however according to the team, there is no reason to suggest that the effect would be any different.

The technique expresses a gene called halorhodopsin – an ‘optogenetic’ tool which allows yellow light to control cells in living tissue, such as neurons that have been genetically adapted.

Image of an outline of a head with blue lines.
Scientists have already discovered that starting treatment with antiepileptic drugs during the epileptogenic process will delay the inevitable onset of seizures. Image is for illustrative purposes only.

Dr Giachello added: “By using this optogenetic tool, we found that if we prevent nervous system activity at a time when the fly embryo is between 80 and 90% fully developed, seizures stop entirely.

“Optogenetics is a recent development in biology which is causing quite a bit of excitement, not just in the treatment of epilepsy but other illnesses too.”

Scientists have identified many genes that make humans predisposed to epilepsy. The identification of these genes makes it possible to screen for the disease before it starts and, as this new research shows, it might be possibly to intervene to prevent it.

About this epilepsy research

Joining McDermott in this research were lead coauthors Philsang Hwang and Shih-Wei Chou and contributing author Zongwei Chen.

Funding: This research was funded by Medical Research Council.

Source: Mike Addelman – University of Manchester
Image Credit: The image is in the public domain
Original Research: Full open access research for “Inappropriate Neural Activity during a Sensitive Period in Embryogenesis Results in Persistent Seizure-like Behavior” by Carlo N.G. Giachello and Richard A. Baines in Current Biology. Published online November 5 2015 doi:10.1016/j.cub.2015.09.040


Abstract

Inappropriate Neural Activity during a Sensitive Period in Embryogenesis Results in Persistent Seizure-like Behavior

Highlights
•Activity manipulation defines a critical period for circuit functionality
•Abnormal activity during the critical period induces seizure
•Early drug intervention prevents seizure occurrence at postembryonic stages
•Seizure behavior correlates with aberrant synaptic excitation of motoneurons

Summary
Maturation of neural circuits requires activity-dependent processes that underpin the emergence of appropriate behavior in the adult. It has been proposed that disruption of these events, during specific critical periods when they exert maximal influence, may lead to neurodevelopmental diseases, including epilepsy [ 1–3 ]. However, complexity of neurocircuitry, coupled with the lack of information on network formation in mammals, makes it difficult to directly investigate this hypothesis. Alternative models, including the fruit fly Drosophila melanogaster, show remarkable similarities between experimental seizure-like activity and clinical phenotypes [ 4–6 ]. In particular, a group of flies, termed bang-sensitive (bs) mutants have been extensively used to investigate the pathophysiological mechanisms underlying seizure [ 7–12 ]. Seizure phenotype can be measured in larval stages using an electroshock assay, and this behavior in bs mutants is dramatically reduced following ingestion of typical anti-epileptic drugs (AEDs; [ 13 ]). In this study we describe a critical period of embryonic development in Drosophila during which manipulation of neural activity is sufficient to significantly influence seizure behavior at postembryonic stages. We show that inhibition of elevated activity, characteristic of bs seizure models, during the critical period is sufficient to suppress seizure. By contrast, increasing neuronal excitation during the same period in wild-type (WT) is sufficient to permanently induce a seizure behavior. Further, we show that induction of seizure in WT correlates with functional alteration of motoneuron inputs that is a characteristic of bs mutants. Induction of seizure is rescued by prior administration of AEDs, opening a new perspective for early drug intervention in the treatment of genetic epilepsy.

“Inappropriate Neural Activity during a Sensitive Period in Embryogenesis Results in Persistent Seizure-like Behavior” by Carlo N.G. Giachello and Richard A. Baines in Current Biology. Published online November 5 2015 doi:10.1016/j.cub.2015.09.040

Feel free to share this neuroscience news.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.